Industry Experts

Nagendra Chemuturi received his Bachelor Degree in Pharmacy, with Distinction and two gold medals, from Kakatiya University, India. He worked as a pharmaceutical sales representative before pursuing his Ph.D. at the University of Iowa. He was awarded the AAPS Graduate Symposium Award in 2005 for his dissertation work on the role of nasal drug transporters and metabolism in preferential nose-to-brain uptake of dopamine into brain. He started his career in the US at Vertex Pharmaceuticals in 2005. Since then, he has worked at both big (Alcon-Novartis and Takeda) and mid-size pharma (Seattle Genetics) and is currently with Eli Lilly as Senior Director in ADME Department. His expertise lies in the fields of oncology, rare diseases and ophthalmology having served as lead on several small and large molecule projects. He is currently working on viral and non-viral genetic medicines (gene therapies) for treating rare diseases, cancers and other indications. He has given podium presentations at several scientific conferences, and is active in IQ consortium, AAPS and Boston Society-APA. He has co-authored several articles and book chapters.